|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of right-of-use assets | |||||
| Unrealized loss on investment | |||||
| Gain on extinguishment of liabilities | |||||
| Share-based compensation expense | |||||
| Changes in operating assets and liabilities: | |||||
| Trade and other receivables | |||||
| Prepaid and other assets | |||||
| Trade and other payables | |||||
| Accrued employee benefits | |||||
| Lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock, pre-funded warrants, and common warrants | |||||
| Proceeds from exercise of pre-funded warrants, Series 2 warrants and common warrants | |||||
| Net cash provided by financing activities | |||||
| Effects of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, Beginning of period | |||||
| Cash, cash equivalents, and restricted cash, End of period | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Supplemental Cash Flow Elements | |||||
| Supplemental cash flow information: | |||||
| Initial measurement of operating lease right-of-use assets and liabilities | |||||
| Re-measurement of operating lease right-of-use assets and liabilities | |||||
| Deemed dividend | |||||
Loading...